New FDA-approved screening options make colorectal cancer detection easier than ever, with 91% survival rates when caught ...
Identical stool samples sent to seven direct-to-consumer microbiome testing companies produced substantially different bacterial profiles and health assessments. Across 18 commonly reported microbial ...
Oct 28 (Reuters) - Laboratory services provider Labcorp (LH.N), opens new tab forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to ...
SALT LAKE CITY — A Utah-based artificial intelligence company and scientists at ARUP Laboratories on Tuesday announced the development of an AI tool that detects intestinal parasites in stool samples ...
Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially ...
If you are having digestive symptoms, your doctor may prescribe an at-home stool test, in which you collect stool samples and send them to a lab or bring them to your doctor’s office for analysis.
Geneoscopy’s New FDA-Approved Stool Collection Method Simplifies At-Home Colorectal Cancer Screening
Pairing diagnostic innovation with improved patient experience, ColoSense aims to streamline the screening process and increase compliance ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences ...
June 23 (Reuters) - When the U.S. Supreme Court earlier this year agreed to take up medical testing company Laboratory Corporation of America’s appeal of a class certification order, it was one of the ...
The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...
Diets in wealthier countries often include processed foods that contain additives, particularly emulsifiers. These additives are increasingly associated with the development of various diseases, ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease ST. LOUIS & HERCULES, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results